PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
BTAI vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

BTAI vs. SPY

Last updated May 12, 2025

Compare and contrast key facts about BioXcel Therapeutics, Inc. (BTAI) and SPDR S&P 500 ETF (SPY).

SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTAI or SPY.

Correlation

The correlation between BTAI and SPY is 0.95, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

BTAI vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioXcel Therapeutics, Inc. (BTAI) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

BTAI:

71.04%

SPY:

20.02%

Max Drawdown

BTAI:

-10.53%

SPY:

-55.19%

Current Drawdown

BTAI:

-10.53%

SPY:

-7.65%

Returns By Period

BTAI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

SPY

YTD

-3.42%

1M

5.69%

6M

-5.06%

1Y

9.73%

5Y*

16.26%

10Y*

12.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

BTAI vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BTAI
The Risk-Adjusted Performance Rank of BTAI is 77
Overall Rank
The Sharpe Ratio Rank of BTAI is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of BTAI is 11
Sortino Ratio Rank
The Omega Ratio Rank of BTAI is 33
Omega Ratio Rank
The Calmar Ratio Rank of BTAI is 11
Calmar Ratio Rank
The Martin Ratio Rank of BTAI is 1515
Martin Ratio Rank
SPY
The Risk-Adjusted Performance Rank of SPY is 6969
Overall Rank
The Sharpe Ratio Rank of SPY is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 6767
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7171
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7474
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BTAI vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioXcel Therapeutics, Inc. (BTAI) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data
No data

Loading data...

Dividends

BTAI vs. SPY - Dividend Comparison

BTAI has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.27%.

TTM20242023202220212020201920182017201620152014
BTAI
BioXcel Therapeutics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF		1.27%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

BTAI vs. SPY - Drawdown Comparison

The maximum BTAI drawdown since its inception was -10.53%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BTAI and SPY. For additional features, visit the drawdowns tool.

Loading data...

Volatility

BTAI vs. SPY - Volatility Comparison

Loading data...